FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds, which can be used as inhibitors of protease of hepatitis C virus, pharmaceutical compositions, containing the said compounds, and methods of their application.
EFFECT: obtaining compounds which can be used as inhibitors of protease of hepatitis C virus.
41 cl, 10 dwg, 7 tbl, 26 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITORS OF PROTEASE OF HEPATITIS C VIRUS AND THEIR APPLICATION | 2008 |
|
RU2515318C2 |
| METHOD OF DETERMINING INHIBITOR, COVALENTLY BINDING TARGET POLYPEPTIDE | 2009 |
|
RU2542963C2 |
| HETEROARYL COMPOUNDS AND USING THEM | 2009 |
|
RU2536584C2 |
| PI3-KINASE INHIBITORS AND USE THEREOF | 2010 |
|
RU2595718C2 |
| MACROCYCLIC SERINE PROTEASE INHIBITORS | 2009 |
|
RU2490272C2 |
| HCV NS3 PTOTEASE INHIBITORS | 2007 |
|
RU2468029C2 |
| SERINE PROTEASE INHIBITORS | 2006 |
|
RU2441020C2 |
| INHIBITORS OF SERINE PROTEASES, IN PARTICULAR, HC-3-HC4A PROTEASE | 2004 |
|
RU2412198C2 |
| HETEROARYL COMPOUNDS AND USE THEREOF | 2009 |
|
RU2734822C2 |
| 2-AMIDO-4-ARYLOXY-1-CARBONYLPYRROLIDINE DERIVATIVES AS SERINE PROTEASE INHIBITORS, PARTICULARLY NS3-NS4A HCV PROTEASE | 2004 |
|
RU2440368C2 |
